At the ninth month of the follow-up, as calcitriol treatment was used in a dose higher than that prescribed (3x0.5 μg/dose instead of 3x0.25 μg/dose), serum PTH level decreased below normal ranges and urinary analysis revealed hypercalciuria. This evidence concerns the gene PTH and Hypercalciuria.